MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Remyelination

Home
Remyelination
remyelination

Facebook Live: Remyelination – March 2020

MStranslate
March 11, 2020
Q&A, Remyelination, Videos
1 Comment
On March 5, 2020, Brett Drummond (Co-Founder of MStranslate and Chief Science Communicator) held a Facebook Live event to explain and discuss one of the most important topics in multiple sclerosis research,...
myelin repair

Fasting & Metformin Improve Myelin Repair

MStranslate
October 9, 2019
Remyelination, Research, Videos
4 Comments
A newly published study from the University of Cambridge has found that fasting, as well as a common diabetes drug that mimics fasting, can improve myelin repair. In the below video, our co-founder and...
stem cells

Stem Cells in Hair Follicles Show Myelin Repair Potential

MStranslate
April 30, 2019
Remyelination, Research, Stem Cells
Research Summary: CD34 defines melanocyte stem cell subpopulations with distinct regenerative properties Myelin repair or remyelination is considered by many, including an overwhelming majority of our...
myelin repair microglia

Myelin Repair: Cellular Switch Identified?

MStranslate
July 24, 2018
Basic Sciences, Progressive MS, Remyelination, Research
1 Comment
PROGRESSIVE MULTIPLE SCLEROSIS AND MYELIN REPAIR We have seen an increasing number of powerful new treatments developed recently for relapsing remitting multiple sclerosis.  These treatments work in various...

Regulatory T Cells Promote Remyelination

MStranslate
March 26, 2017
Remyelination, Research
Research Summary: Regulatory T cells promote myelin regeneration in the central nervous system When we think about treating multiple sclerosis, generally there are two main approaches that are discussed. ...
Antihistamine

Antihistamine may stimulate myelin repair

MStranslate
April 13, 2016
Clinical Trials, Remyelination, Research, Treatments
1 Comment
A small, Phase II clinical trial has shown that a common over the counter antihistamine, called clemastine fumarate, has the ability to partially reverse damage to the optic nerve in people with multiple...

Remyelination in MS: Novoron Bioscience

MStranslate
January 28, 2016
Dr Travis Stiles, Remyelination, Research, Treatments
INTERVIEW WITH DR TRAVIS STILES – CEO, NOVORON BIOSCIENCE BD: Brett Drummond, MStranslate TS: Dr Travis Stiles, Novoron Bioscience BD:  So welcome everyone to our video today.  This video has come...
  1. 1
  2. 2

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.